학술논문
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
Document Type
Article
Author
Ader, F.; Peiffer-Smadja, N.; Belhadi, D.; Lescure, F.-X.; Bouadma, L.; Peytavin, G.; Yazdanpanah, Y.; Burdet, C.; Mentré, F.; Poissy, J.; Nseir, S.; Bouscambert-Duchamp, M.; Lina, B.; Dupont, A.; Alfaiate, T.; Diallo, A.; Mercier, N.; Delmas, C.; Saillard, J.; Dechanet, A.; Raffi, F.; Goehringer, F.; Kimmoun, A.; Jaureguiberry, S.; Reignier, J.; Danion, F.; Clere-Jehl, R.; Bouiller, K.; Navellou, J.-C.; Tolsma, V.; Cabié, A.; Dubost, C.; Courjon, J.; Leroy, S.; Mootien, J.; Gaci, R.; Mourvillier, B.; Faure, E.; Pourcher, V.; Lacombe, K.; Costagliola, D.; Gallien, S.; Launay, O.; Lanoix, J.-P.; Makinson, A.; Martin-Blondel, G.; Botelho-Nevers, E.; Gagneux-Brunon, A.; Epaulard, O.; Piroth, L.; Wallet, F.; Richard, J.-C.; Reuter, J.; Staub, T.; Noret, M.; Andrejak, C.; Lê, M.P.; Hites, M.
Source
In: Clinical Microbiology and Infection . (Clinical Microbiology and Infection, December 2021, 27(12):1826-1837)
Subject
Language
English
ISSN
14690691
1198743X
1198743X